Welcome to your daily round-up of everything happening in the world of neurorehab.
Research
More than half a million global stroke deaths may be tied to climate change
A changing climate may be linked to growing death and disability from stroke in regions around the world, according to a study. Researchers found over three decades that non-optimal temperatures, those above or below temperatures associated with the lowest death rates, were increasingly linked to death and disability due to stroke.
Newly found genetic variant defends against Alzheimer’s disease
Neuroscientists have identified a genetic mutation that fends off Alzheimer’s disease in people at high risk and could lead to a new way to protect people from the disease.
Multifractal analysis could detect early stages of multiple sclerosis
Researchers behind a new study have demonstrated that multifractal analyses of electrical signals flowing from the brain, could be a promising tool for early detection of the severity of MS.
Geraniol attenuates oxidative stress and cognitive impairment
In a new study, D-galactose (D-gal) administration was proven to induce cognitive impairment and aging in rodents’ models. Geraniol (GNL), which belongs to the acyclic isoprenoid monoterpenes, reduces inflammation by changing important signaling pathways and cytokines, and is plausible to be used as a medicine for treating inflammatory disorders.
Policy updates
MND tool raised in parliamentary Early Day Motion
Kevin Stewart, MSP for Aberdeen Central, raised research by the University of Aberdeen that identified a new tool to detect signs of motor neuron disease (MND) before symptoms begin.
Company news
Roche granted FDA Breakthrough Device Designation for Alzheimer’s blood test
The Elecsys® pTau217 plasma biomarker test is being developed as part of an ongoing partnership between Roche and Eli Lilly and Company. Once approved, the test will aid healthcare providers in identifying amyloid pathology, a key feature of Alzheimer’s disease.
Magnetic Insight receives $3 million in new grant funding
Magnetic Insight was awarded a multi-million-dollar NIH Phase II Small Business Innovative Research (SBIR) grant to develop the engineering underpinning its clinical MPI imaging platform development, which is focused on accelerating imaging applications for CAR-T cell therapies, stroke, gastrointestinal (GI) bleeds, and pulmonary embolisms.
